| AA | Anti-angiogenic agents |
| AT | Achilles tendinopathy |
| AT-MSCs | Adipose tissue-derived mesenchymal stem cells |
| CS | Corticosteroids |
| Coll | Collagen |
| COX | Cyclooxygenase |
| ECM | Extracellular matrix |
| HGF | Hepatocyte growth factor |
| IL | Interleukin |
| Lr-PRP | Leucocyte-rich PRP |
| Lp-PRP | Leucocyte-poor PRP |
| MIF | Macrophage migration inhibitory factor |
| MMPs | Matrix metalloproteinases |
| MSC | Mesenchymal stem cells |
| PGE2 | Prostaglandine E2 |
| PRP | Platelet-rich plasma |
| PRST | Percutaneous soft tissue release |
| TEM | Transmission electron microscopy |
| TGF-β | Transforming growth factor β |
| TIMPs | Tissue inhibitors of metalloproteinase |
| TLC | Tenocyte-like cells |
| TNF | Tumor necrosing factor |
| TSCs | Tendon stem cells |
| SP | Substance P |
| VAS | Visual analogic scale |
| VEGF | Vascular endothelial growth factor |
| VISA | Victorian Institute of Sports Assessment self-administered |